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Activity-based protein profiling is an invaluable tech-
nique for studying enzyme biology and facilitating
the development of therapeutics. Ubiquitin E3 li-
gases (E3s) are one of the largest enzyme families
and regulate a host of (patho)physiological pro-
cesses. The largest subtype are the RING E3s of
which there are >600 members. RING E3s have
adaptor-like activity that can be subject to diverse
regulatory mechanisms and have become attractive
drug targets. Activity-based probes (ABPs) for
measuring RING E3 activity do not exist. Here we
re-engineer ubiquitin-charged E2 conjugating en-
zymes to produce photocrosslinking ABPs. We
demonstrate activity-dependent profiling of two
divergent cancer-associated RING E3s, RNF4 and
c-Cbl, in response to their native activation signals.
We also demonstrate profiling of endogenous RING
E3 ligase activation in response to epidermal growth
factor (EGF) stimulation. These photocrosslinking
ABPs should advance E3 ligase research and the
development of selective modulators against this
important class of enzymes.
INTRODUCTION
Ubiquitination is fundamental posttranslational modification
that regulates normal cellular physiology and its dysfunction
can lead to disease onset (Rape, 2018). Ubiquitination is car-
ried out by an enzymatic cascade involving the sequential ac-
tivities of ubiquitin E1-activating (E1), ubiquitin E2-conjugating
(E2), and ubiquitin E3 ligases (E3s) (Hershko and Ciechanover,
1998). Ubiquitin (Ub) is covalently transferred from catalytic
cysteine in E1 onto catalytic cysteine in E2 forming a thio-
ester-linked E2 intermediate (E2Ub). Hundreds of E3s are
known to exist which recruit E2Ub and ubiquitinate-specific
substrates. Divergence of E3 mechanism has led to two gen-
eral classes. ‘‘Cys E3s,’’ of which there are 50, utilize a cata-
lytic cysteine to form a covalent thioester-linked intermediate
with the Ub before substrate modification (Scheffner et al.,
1995; Wenzel et al., 2011; Pao et al., 2018). However, the
largest class are adapter-like E3s of which there are >600Celldistinct forms (Deshaies and Joazeiro, 2009). Adapter-like
E3s are devoid of a catalytic nucleophile and catalyze direct
transfer of Ub from E2Ub to substrate. This adapter-like activ-
ity is utilized by multi-subunit Cullin-RING E3s and 350 single
polypeptide RING E3s (hereafter simply referred to as RING
E3s). The latter can exist as monomers, homodimers, or heter-
odimers (Metzger et al., 2014). Activity regulation is a particu-
larly important aspect of E3 biology that ensures cellular
homeostasis and adaptive signaling. Dysregulation can lead
to disease onset hence RING E3s have become attractive ther-
apeutic targets (Burgess et al., 2016). However, the cellular
roles and the regulatory mechanisms for the vast majority of
RING E3s remain poorly understood. Furthermore, RING E3s
have recently been shown to be compatible with targeted pro-
tein degradation strategies (e.g., PROTAC methodology) (Naito
et al., 2019; Spradlin et al., 2019; Ward et al., 2019), so tools for
determining which are active in clinical contexts are needed to
further leverage this potential.
A hallmark of adapter-like E3s is that when in the active
state, they shift the dynamic E2Ub conformational ensemble
toward a distinct population where the E2Ub conjugate
adopts a folded back or ‘‘closed’’ conformation (Pruneda
et al., 2011, 2012; Dou et al., 2012b; Plechanovova´ et al.,
2012) (Figure 1A). This conformation activates the thioester
bond within E2Ub to nucleophilic attack and is a requisite
for efficient aminolysis activity. RING E3 activity can be regu-
lated and switching to an activated state is achieved by the
E3 acquiring structural features that engage the Ub compo-
nent thereby promoting induction of the closed conformation.
For example, RING E3s such as RNF4 and BIRC7 are acti-
vated by RING domain dimerization where a tail region of the
second RING protomer engages the Ub component (Dou
et al., 2012b; Plechanovova´ et al., 2012). Dimerization can
be regulated by cellular signals and in the case of RNF4, this
is brought about by binding to poly-SUMO chains (Rojas-Fer-
nandez et al., 2014).
For activation of monomeric RING E3s a so-called non-RING
element has been shown to play a role in binding the Ub
component and, in the case of Cbl-b and c-Cbl, this is a phos-
phorylated tyrosine residue (Dou et al., 2013). Phosphorylation
is carried out by the kinase c-Src in response to growth factor
stimulation and Cbl activation triggers the ubiquitination and
degradation of receptor and non-receptor tyrosine kinases
(Levkowitz et al., 1998, 1999; Yokouchi et al., 2001). RING
E3s that require dimerization and the presence of a non-
RING element have also been reported (Koliopoulos et al.,Chemical Biology 27, 1–9, January 16, 2020 ª 2019 Elsevier Ltd. 1
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Figure 1. Strategy and Synthetic Scheme for Production of Photocrosslinking ABPs for RING E3 Ligases
(A) Binding of activated RING E3 induces closed conformation of otherwise conformationally dynamic E2Ub conjugate. Activation can be achieved by RING
dimerization whereas monomeric RING E3s can be activated by the presence of a non-RING element (NRE). The Ub component of E2Ub interacts with RING/
NRE region.
(B) Judicious incorporation of a p-benzoyl-L-phenyl alanine (Bpa) crosslinking amino acid within a stabilized E2Ub conjugate serves as an ABP for RING E3
activity.
(C) Crystal structure of E2Ub in complex with activated, dimeric RING E3 (RNF4; PDB: 4AP4). Ten amino acid sites within Ub that are proximal to the activated
E3 were tested for Bpa incorporation. The Q31 (highlighted in red) was found to be optimal.
(D) Synthetic scheme for photocrosslinking ABP.
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cluding allosteric binding of accessory proteins or ligands
(DaRosa et al., 2015; Dickson et al., 2018; Duda et al., 2012;
Wright et al., 2016). Numerous crystal structures of E2Ub
bound to activated RING E3s have been solved revealing a
highly conserved binding mode (Dou et al., 2012b, 2013; Kolio-
poulos et al., 2016; Plechanovova´ et al., 2012; Wright et al.,
2016). Importantly, a consensus region of the Ub component
in the closed E2Ub conjugate becomes proximal to the acti-
vated RING. Furthermore, biophysical analysis demonstrates
that activated RING E3s studied thus far can have higher free
energy of binding for E2Ub than their inactive forms (Bernd-
sen et al., 2013; Buetow et al., 2016).
Activity-based probes (ABPs) are powerful chemical tools that
undergo activity-dependent covalent labeling of enzyme family
members (Niphakis and Cravatt, 2014; Hewings et al., 2017).
This enables: (1) the study of enzyme regulation, (2) discovery
of novel enzyme classes, (3) inhibitor screening, (4) inhibitor
selectivity profiling, and (5) stabilization of enzymatic intermedi-
ates for structural studies (Hu et al., 2002). We and others have
developed ABPs for Cys E3s which have been deployed to
dissect E3 activation mechanisms and discover entirely novel
E3 classes (Love et al., 2009; Pao et al., 2016, 2018; Mulder
et al., 2016; Xu et al., 2019). ABPs that accurately assess RING
E3 ligase activity do not currently exist.2 Cell Chemical Biology 27, 1–9, January 16, 2020We reasoned that the conserved (and activity-dependent)
consensus interaction of the Ub component within the closed
E2Ub, coupled with the enhanced free energy of binding for
activated RING E3s, could be exploited for the development of
ABPs for RING E3s. An ABP could then be based on an engi-
neered E2Ub conjugate where the labile cysteine thioester
has been replaced with a more stable linkage chemistry such
as a lysine isopeptide (Plechanovova´ et al., 2012). However,
ABPs typically contain an electrophilic warhead that covalently
labels a catalytic nucleophile within the enzyme family under
investigation. As RING E3s utilize an adapter-like mechanism,
devoid of a catalytic nucleophile, we reasoned that rational
placement of a photocrosslinking moiety within the E2Ub con-
jugate would compensate for the absence of this catalytic
feature (Figure 1B). Such a strategy has been successfully em-
ployed for metalloenzymes that also lack a catalytic residue
(Saghatelian et al., 2004). Incorporation of photocrosslinking
groups into polymeric ubiquitin species have also been reported,
where these serve as photoaffinity probes for generic Ub interac-
tors (Chojnacki et al., 2017; Liang et al., 2017). The utility of pho-
tocrosslinker incorporation into E2s for E3 study has also been
demonstrated. Crosslinker incorporation by chemical labeling
has enabled the mapping of Cys E3 catalytic residues (Krist
and Statsyuk, 2015) and, more recently, incorporation into an
E2 by chemical synthesis has been used to generate a
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Figure 2. Assembly and Characterization of
photoABP
(A) SDS-PAGE analysis of representative enzymatic
conjugation of UbBpa31 to E2 (UBE2D3 C85K
S22K double mutant) with ubiquitin E1 activating
enzyme. Asterisk corresponds to a presumed diu-
biquitin species.
(B) Representative purification fractions of probe
product after size-exclusion chromatography.
(C) Reverse-phase high-performance liquid chro-
matography chromatogram for purified photoABP-
Bpa31.
(D) Deconvoluted mass spectrum for photoABP-
Bpa31. Observed mass = 27,901 Da, observed
mass (-Met) = 27,771 Da. Expected mass =
27,908.87 Da, expectedmass (-Met) = 2,777.67 Da.
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https://doi.org/10.1016/j.chembiol.2019.11.013photoaffinity probe for a SUMOE3 (Zhang et al., 2019). However,
the utility of these technologies as ABPs has not been
demonstrated.
RESULTS
Design and Assembly of Photocrosslinking RING ABPs
To establish potential positions for photocrosslinker incorpora-
tion we generated structural superpositions for solved RING
E3:E2Ub cocrystal structures (Figure S1) (Dou et al., 2012b,
2013; Koliopoulos et al., 2016; Plechanovova´ et al., 2012). Strik-
ing conservation in bindingmodewas apparent andmultiple res-
idues within both Ub and E2 lie proximal to the RING domain(s).
To impart activity dependence to the probe we incorporated the
photocrosslinking moiety into Ub as unlike the E2, this compo-
nent only binds proximally to active RING E3s. We chose ten
consensus sites within Ub that are proximal to activated RINGs
(Figure 1C) and incorporated the photocrosslinking amino acid
p-benzoyl-L-phenylalanine (Bpa) using an evolved Methanocal-
dococcus jannaschii tyrosyl-tRNA synthetase (MjYRS)-tRNACUA
pair (Figures 1B and 1C) (Chin et al., 2002). Efficient incorpora-
tion was achieved at all sites yielding4–6 mg of protein per liter
of culture medium. Ub mutants were purified to homogeneity
and characterized by liquid chromatography-mass spectrom-
etry (LC-MS) (Figure S2). All of the mutant Ub variants were
then enzymatically conjugated to the promiscuous E2 UBE2D3
(Brzovic and Klevit, 2006), bearing an N-terminal hexahistidine
tag (Figure 1D). In addition to facilitating purification, the latter
serves as a convenient reporter tag for immunoblot analysis.
Conjugation to E2 was carried out with E1 activating enzyme
and, to form a more stable linkage between Ub and E2, the cat-
alytic cysteine was mutated to lysine enabling stable isopeptide
conjugation (Plechanovova´ et al., 2012) (Figure 2A). Importantly,
structural analysis has shown that the isopeptide is an accept-
able structural mimetic of the native thioester (Koliopoulos
et al., 2016; Plechanovova´ et al., 2012; Wright et al., 2016). WeCell Chalso introduced an S22R mutation into
the E2 component, which disrupts a non-
covalent Ub binding site that could result
in ABP self-association (Brzovic et al.,
2006). All E2Ub variants were purified
to homogeneity by size-exclusion chro-matography as determined by SDS-PAGE and LC-MS analysis
(Figures 2B–2D and S3A).
Activity-Dependent Profiling of the Dimeric RING
E3 RNF4
The RING E3 RNF4 is inactive in the monomeric state, which is
predominant at endogenous concentrations. Binding of poly-
SUMO chains to SUMO-interacting motifs (SIMs) within RNF4
enhances the local concentration of RNF4 thereby promoting
RING domain homodimerization and activation of E3 ligase ac-
tivity (Rojas-Fernandez et al., 2014). This leads to ubiquitination
and degradation of SUMO-modified promyelocytic leukemia
protein (Tatham et al., 2008). Strikingly, therapeutic induction
of this process leads to remission of acute promyelocytic leuke-
mia in >90% of cases (Massaro et al., 2016). An engineered
version of RNF4 that is constitutively active has been designed
that consists of full-length protein with an additional RING
domain fused to the native C terminus via a flexible linker
(RNF4-RING) (Figure 3A) (Plechanovova´ et al., 2011). To deter-
mine the optimum photocrosslinker position we incubated all
tenBpamutant E2Ubconjugateswith RNF4-RING (Figure S3B)
and assessed crosslinking efficiency upon UV irradiation
(10 min). Significant and dose-responsive crosslinking was
only observed with Bpa incorporation at position 31 (photo-
ABP-Bpa31) (Figures 3B and S3C). Importantly, no crosslinking
was observed when RNF4-RING was incubated and UV irradi-
ated with unconjugated UbBpa31, indicating that the photo-
crossslinking was dependent on E2-driven Ub proximity, consis-
tent with the native mechanism. Notably, an additional
crosslinking product corresponding to the molecular weight
for the addition of two photoABP-Bpa31 molecules was
observed (Figure 3B). Structural studies on dimeric RING:E2Ub
complexes has revealed that both faces of the active RING dimer
engage and activate a separate E2Ub conjugate. By virtue of
the fused RNF4-RING construct it is possible to disrupt binding
to a single E2Ub molecule, or both, by introducing an M140Aemical Biology 27, 1–9, January 16, 2020 3
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Figure 3. Activity-Dependent Profiling of RNF4 E3 Ligase Activity
(A) Constitutively active RNF-RING fusion protein can productively engage two E2Ub conjugates.
(B) Probe photoABP-Bpa31 (40 mM) undergoes two crosslinking reactions with RNF4-RING (10 mM).
(C) Engagement of one or both E2Ub conjugates can be disrupted with a M140A R181A double mutation introduced into one or both RING domains in
RNF4-RING.
(D) Probe photoABP-Bpa31 (20 mM) crosslinking is attenuated or abolished depending on whether one or both RING domains are mutated.
(E) Introduction of a F62A mutation into the E2 component should abolish E3 binding.
(F) Crosslinking is abolished with the photoABP-Bpa31 F62A (probe concentration 40 mM).
(G) At concentrations below the Kd for dimerization, RNF4 is inactive. Binding of poly-SUMO chains induces dimerization and E3 ligase activity.
(H) photoABP-Bpa31 (5 mM) undergoes poly-SUMO chain (10 mM) dependent crosslinking of native RNF4 (100 nM) whereas RINF4-RING (50 nM) crosslinks
independent of poly-SUMO chains. IB denotes immunoblot and the primary antibody used for detection is adjacent (i.e., anti-RNF4).
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(RNF4x-RING or RNF4x-RINGx, respectively) (Figure 3C) (Ro-
jas-Fernandez et al., 2014). Consistent with photoABP-Bpa31
profiling this structurally elucidated bipartite mechanism, cross-
linking of the second photoABP-Bpa31 molecule was lost with
RNF4x-RING and was completely abolished with RNF4x-RINGx
(Figure 3D). To further confirm activity-dependent photocros-
slinking we prepared a mutant photoABP-Bpa31 control probe.
Part of the conserved E2-RING interaction involves the E2 F62
residue (F63 in some model E2s) and mutation to alanine typi-
cally impairs/abolishes E3 binding (Figure 3E) (Weissman,
2001). This control probe would further inform on whether
observed labeling is consistent with a native E2-RING interac-
tion, thus suitable for screening inhibitors that disrupt the
native interaction. Consistent with the probe being engaged
in a native manner, the photoABP-Bpa31 F62A probe did not
undergo RING crosslinking (Figure 3F). This probe should
also serve as a valuable control when profiling RING E3s
agnostically.
ABP Profiling of Poly-SUMO Chain-Induced RNF4
Activation
Cellular RNF4 is activated by recruitment to poly-SUMO chains
via its SIM domains thereby inducing dimerization. The Kd of
dimerization is 180 nM (Rojas-Fernandez et al., 2014) so by
working at concentrations below this value we established a
biochemical assay to assess whether photoABP-Bpa31 could
profile poly-SUMO chain-induced activation of native RNF4 (Fig-
ure 3G). As expected, constitutively active RNF4-RING was
insensitive to dilution and underwent photoABP-Bpa31 cross-
linking but native RNF4 did not (Figure 3H). However, in the pres-
ence of a linear amide-linked tetra-SUMO (SUMOx4) fusion pro-
tein (10 mM), which recapitulates the activation properties of
native isopeptide-linked poly-SUMO chains (Tatham et al.,
2008), photoABP-Bpa31 crosslinking was observed with an
efficiency comparable with that of RNF4-RING. Insightfully, a
crosslinked band was observed for addition of a second photo-
ABP-Bpa31 molecule (Figure 3H). This suggests that natively
activated wild-type RNF4 retains its bipartite activity and its
associated processivity is presumably utilized in cells. Taken
together, the data so far demonstrate that photoABP-Bpa31 un-
dergoes activity-dependent crosslinking of a natively activated
RING E3, which is devoid of a catalytic nucleophile.
Activity-Dependent Profiling of Phosphorylation-
Induced RING E3 Activation
We next tested photoABP-Bpa31 with a RING E3 that activates
via a distinct mechanism. The Cbl proteins are multidomain and
multifunctional RING E3 ligases consisting of three homologs:
c-Cbl, Cbl-b, and Cbl-c (Lyle et al., 2019). The majority of Cbl
function is associated with RING E3 activity and involves regu-
lation of angiogenesis and aberrations in Cbl activity have been
implicated with a number of cancers. Cbl is overexpressed in
many breast cancer cells and tissues and is also found to be
downregulated in human myeloid neoplasms, and non-small-
cell lung cancers (Kales et al., 2010; Tan et al., 2010). Hence,
modulation of Cbl E3 activity is an attractive therapeutic strat-
egy and has attracted considerable interest from the pharma-
ceutical industry. The most common mutation manifesting inthe clinic is at residue Y371. Y371 is subject to growth fac-
tor-induced phosphorylation by c-Src kinase and this leads to
structural changes that present a non-RING element, enhance
affinity for E2Ub, and stimulate Cbl E3 activity (Buetow et al.,
2016; Dou et al., 2013). Indeed, the affinity for Cbl phosphory-
lated at Y371 (c-Cbl pTyr371) enhances E2Ub affinity
30-fold (Buetow et al., 2016).
To assess whether photoABP-Bpa31 can profile Src-depen-
dent activation of c-Cbl E3 activity we incubated recombinant
Src with Cbl and Cbl Y371F, the latter expected to be
refractory to phosphorylation-induced activation. PhotoABP-
Bpa31 crosslinking was observed for c-Cbl in the presence of
c-Src but not for c-Cbl Y371F, nor when c-Src was withheld
(Figure 4A). Labeling was again abolished with the photoABP-
Bpa31 F62A control probe (Figure S3D), and was also ATP
dependent (Figure S3E). Therefore, consistent with previous
studies, phosphorylation at Y371 specifically is required for
activation of E3 activity (Dou et al., 2013). We also tested the
panel of engineered E2Ub conjugates with Bpa incorporation
at different positions against c-Src activated c-Cbl and found
partial overlap of productive sites with those for RNF4 (Fig-
ure S3F). An optimal Bpa position was 31 but, unlike RNF4, po-
sition 32 also crosslinked with similar efficiency. This is perhaps
reflective of nuances between the monomeric and dimeric acti-
vation mechanism exhibited by these two RING E3s (Dou et al.,
2013; Plechanovova´ et al., 2012). Interestingly, photocrosslink-
ing efficiency remained substoichiometric regardless of photo-
ABP-Bpa31 concentration suggestive of a subpopulation of
the recombinant protein preparation being active (Figure S3G).
Although Phos-tag gel analysis indicated that Cbl was quantita-
tively phosphorylated (Figure S3H), Src is known to phosphor-
ylate multiple sites within Cbl and the degree of probe labeling
may reflect substoichiometric phosphorylation at position Y371
(Dou et al., 2012a). We tested if incubation with elevated
concentrations of Src could enhance photocrosslinking effi-
ciency but found that as concentrations approached stoichi-
ometry, photocrosslinking was inhibited; presumably due to
Src competition with photoABP-Bpa31 for Cbl binding (data
not shown).
Profiling c-Cbl Activation in a Human Cell Line
To establish whether we could profile c-Cbl activation in a human
cell line we transiently transfected HEK293 cells with GST-
tagged c-Src (GST-Src) together with GFP-tagged c-Cbl (GFP-
Cbl) or GFP-tagged c-Cbl Y371F (GFP-Cbl Y371F). To prevent
potential degradation of activated Cbl due to autoubiquitination
we treated cells with the proteasome inhibitor MG132 for 90 min
before lysis. Activity-dependent crosslinking was strictly depen-
dent on Src coexpression and the presence of Y371 but absent
with the photoABP-Bpa31 F62A control probe (Figures 4B
and S4A).
Profiling Endogenous RINGE3Activation in Response to
Growth Factor Stimulation
We next assessed the ability to carry out parallelized profiling of
endogenous RING E3 activation in response to a physiological
stimulus. Such experiments would potentially enable poorly
understood RING E3s to be ascribed to regulatory functions
across a spectrum of both physiological and pathophysiologicalCell Chemical Biology 27, 1–9, January 16, 2020 5
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Figure 4. Activity-Dependent Profiling c-Cbl E3 Ligase Activity and Activity-Based Proteomic Analyses of EGF-Stimulated Versus Unstimu-
lated HEK293T Cells
(A) Only c-Cbl (3 mM) preincubated with c-Src (1.5 mM) undergoes photoABP-Bpa31 (5 mM) crosslinking. Crosslinking is not observed when Cbl Y371 (3 mM),
which cannot be phosphorylated at the activation site, is incubated with Src. Phosphorylation of Cbl results in reduced electrophoretic mobility.
(B) Transient overexpression of GFP-Cbl and c-Src inmammalian HEK293 cells. Extracts were treated with photoABP-Bpa31 or the F62A control probe (5 mM). IB
denotes immunoblot and the primary antibody used for detection is adjacent (i.e., anti-Cbl).
(C) Immunoblot analysis of HEK293T extracts with either photoABP-Bpa31 or the photoABP-Bpa31 F62A control probe (10 mM). Blotting was carried out against
the hexahistidine reporter tag present within the ABPs. Samples were irradiated for 60 min or irradiation was withheld.
(D) Schematic depicting activity-based proteomic workflow with biotinylated photoABP-Bpa31.
(E) Spectral counts obtained from ABP-profiled HEK293T cells. Search results were filtered against the PFAM domain term ‘‘RING’’ and only RING E3s with >2
spectral counts in any replicate experiment were plotted. Cells were serum-starved and either treated with or without EGF and with or without UV irradiation.
Errors bar correspond to the standard error from two technical replicate LC-MS/MS analyses.
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https://doi.org/10.1016/j.chembiol.2019.11.013processes. However, depletion of the ABP by promiscuous
crosslinking might compromise RING E3 coverage and was
initially tested for by immunoblotting against the hexahistidine
reporter tag, which proved not to be the case (Figure 4C).
Furthermore, crosslinking was substantially reduced with the
photoABP-Bpa31 F62A control probe, thereby implying that
many of the crosslinked proteins are likely to be E3s (Figure 4C).
We prepared a biotinylated variant of photoABP-Bpa31 allow-
ing selective enrichment of crosslinked proteins from complex
cellular samples. Bpa was incorporated into N-terminal
cysteine-tagged Ub and labeled with idodoacetyl-PEG2-biotin
(Pao et al., 2018). Biotin labeled UbBpa31 was then enzymati-
cally conjugated to E2 via an isopeptide bond using the proced-
ure for untagged Ub (Figures S4B–S4F). We next tested whether
endogenous Cbl activation could be detected in response to
epidermal growth factor (EGF) stimulation, which induces Cbl6 Cell Chemical Biology 27, 1–9, January 16, 2020phosphorylation (Levkowitz et al., 1998, 1999). HEK293T cells
were stimulated with EGF and, to prevent potential degradation
of activated RING E3s, we prior treated with the proteasome
and lysosomal inhibitors MG132 and bafilomycin, respectively.
Parallel experiments confirmed EGF responsiveness by immu-
noblotting for downstream mitogen-activated protein kinase
activation, which is a robust marker of EGF receptor activation
(Traverse et al., 1992) (Figure S4G).
Extracted proteomes were incubated with biotinylated photo-
ABP-Bpa31 and enriched against streptavidin resin (Pao et al.,
2018) (Figure 4D). Identification of crosslinked proteins and their
probe reactivity was inferred by streptavidin enrichment
followed by data-dependent LC-tandem MS (LC-MS/MS) and
spectral counting (Pao et al., 2018). Twenty-five RING E3s were
detected, including Cbl, and Cbl peptides were only detected in
EGF and UV treated samples (Figure 4E). This suggests that the
Please cite this article in press as: Mathur et al., Photocrosslinking Activity-Based Probes for Ubiquitin RING E3 Ligases, Cell Chemical Biology (2019),
https://doi.org/10.1016/j.chembiol.2019.11.013photocrosslinking probe can detect native RING E3 activation at
the endogenous level. Interestingly, there was a notable increase
in spectral counts for two other RINGE3s, Praja2 and TRIM11 that
was EGF and UV dependent (Figure 4E). As both of these E3s
have been implicated with growth factor signaling, their detection
may also be reflective of their activation or upregulation in
response to EGF stimulation (Di et al., 2013; Rinaldi et al., 2016).
As Ub-interacting surfaces are shared across various ubiquitin
system enzymes, we unexpectedly obtained UV-dependent
enrichment of HECT (11), RBR (1), and RCR (1) E3s, as well as
deubiquitinating enzymes (31) and an E1-activating enzyme (Fig-
ures S4H and S4I). As a consequence, probe modification of
these additional ubiquitin system components could modulate
their activity and in turn alter the activation status, or stability,
of RING E3s under investigation. However, this is unlikely to
pose any limitations beyond those associated with the employ-
ment of cellular extracts where the majority of cellular processes
would be arrested.
DISCUSSION
In summary, we have developed activity-based probes for the
adapter-like activity of RING E3 ligases. We demonstrate an ac-
tivity-dependent signal for RNF4 and c-Cbl in response to their
native activation cues and how the ABP-based readout can
afford further mechanistic insights. These tools allow direct
assessment of RING E3 activity (no dependence on E1, E2, or
substrate) in diverse sample types. We also demonstrate paral-
lelized profiling of a subset of endogenous RING E3s in extracted
proteomes and detect activation of Cbl in response to growth
factor stimulation. Therefore, this technology should find utility
in the study of RING E3 regulatory biology, target discovery,
biomarker applications, and modulator discovery. Detection of
only a subset of RING E3s in our LC-MS/MS experiments might
be reflective of many being inactive or beyond the detection limit
of our current experimental conditions. Another possibility is that
many E3s are not functional with the E2 enzyme photoABP-
Bpa31 is based on (UBE2D3). However, the engineered isopep-
tide conjugation strategy, for stabilizing the labile thioester, has
been demonstrated with E2s that are divergent from the
E2 UBE2D3 employed herein (Branigan et al., 2015; Ordureau
et al., 2015). Hence, our highly modular probe production strat-
egy should be readily applicable to other E2s simply by using
distinct recombinant E2 building blocks. This would potentially
grant broader RING E3 coverage and also provide insights into
cellular E2-E3 interaction networks.
SIGNIFICANCE
The ubiquitin system regulates a host of cellular process in
both health and disease. Hundreds of single polypeptide
RING E3s are encoded by the human genome, yet the
cellular roles and how activity is regulated has only been
demonstrated for a handful of members. Agnostic assess-
ment of the activation status of RING E3s, using the reported
photoABP technology, should facilitate the elucidation of
RING E3 biological function and the discovery of novel reg-
ulatory mechanisms. RING E3s have also become highly
attractive therapeutic targets. However, there is a paucityof methods for measuring RING E3 activity without convo-
luted reconstitution of the E1-E2-E3 cascade. Assessment
of endogenous E3 activity can also be challenging. The pho-
toABPsmight allow the development of simplified and direct
assays for the discovery of therapeutic RING E3modulators.
The ability to parallelize measurements at the endogenous
level by interfacing with mass spectrometry could also facil-
itate comprehensive selective profiling of therapeutic candi-
dates. RING E3s have also recently been shown to be
amenable to targeted protein degradation strategies. To
fully realize this potential it is important to establish which
RING E3smight be active in certain cell types. Here, the pho-
toABPs may find further utility.
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Antibodies
Cbl mouse monoclonal antibody Santa Cruz Biotechnology Cat#Sc-1651; RRID: AB_2244054
6XHis mouse monoclonal antibody Clonetech Cat#631212; RRID: AB_2721905
Anti-mouse antibody IgG, HRP-linked Cell-signalling Technology Cat#7076S; RRID: AB_330924
RNF4 monoclonal antibody Ronald T. Hay University of Dundee
GAPDH mouse monoclonal antibody Proteintech Cat#60004-1-Ig; RRID: AB_2107436
p-ERK1/2 Cell-signalling Technology Cat#9101; RRID: AB_331646
ERK1/2 Cell-signalling Technology Cat#9102; RRID: AB_330744
Bacterial and Virus Strains
BL21 DE3 Merck Cat#69450
Rosetta (DE3) cells- Novagen Merck Cat#7054
Chemicals, Peptides, and Recombinant Proteins
p-Benzoyl-L-phenylalanine (Bpa) Bachem Cat#4017646.0005
t-butyloxycarbonyl-L-lysine (BocK) Bachem Cat#4000211.0025
BugBuster Protein Extraction Merck Millipore Cat#70584
MES-SDS Running Buffer 20X FORMEDIUMTM Cat#MES-SDS5000
MOPS-SDS Running Buffer 20X ThermoFisher Scientific Cat#NP0001
InstantBlueTM Protein Stain Expedeon Cat#ISB1L
His-UBE1 MRC Reagents and Services
University of Dundee
DU32888
UCH-L3 (N-terminal GST) MRC Reagents and Services
University of Dundee
DU21015
TEV protease MRC Reagents and Services
University of Dundee
DU6811
Src (1-536) MRC Reagents and Services
University of Dundee
DU19041
Recombinant epidermal growth factor ThermoFisher Scientific Cat#PHG0311
cOmplete protease inhibitor cocktail (EDTA-free) Roche Diagnostics GmbH Cat#11873580001
Lysozyme Sigma Cat#L6876
Nickel-NTA agarose MRC Reagents and Services
University of Dundee
https://mrcintranet.lifesci.dundee.ac.uk/mrc-reagents
Glutathione sepharose 4B GE Life Sciences #GE17-0756-01
EZ-link iodo-acetyl PEG2-Biotin ThermoFisher Scientific Cat#21334
NuPAGETM LDS Sample Buffer (4X) ThermoFisher Scientific Cat#NP0007
b-mercaptoethanol Sigma-Aldrich Cat#M6250
Sodium Chloride VMR Chemicals Cat#1310-73-2
Dithiothreitol (DTT) Melford Cat#D11000
Trifluoroacetic acid (TFA) Sigma-Aldrich Cat#302031
Acetonitrile Fisher Scientific Cat#A/0627/17
Ampicillin Sigma-Aldrich Cat#A9518
Chloramphenicol Sigma-Aldrich Cat#C0378
Streptomycin Melford Cat#S0188
L-arabinose Sigma-Aldrich Cat#A3256
isopropyl b-D-1-thiogalactopyranoside (IPTG) Melford Cat#156000
Tris VMR Chemicals Cat#10317P
Sodium di-basic phosphate Na2HPO4 Sigma-Aldrich Cat#S5136
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Tris(2-carboxyethyl)phosphine hydrochloride
(TCEP)
Melford Cat#I236500
Imidazole Sigma-Aldrich Cat#I2399
Magnesium Chloride (MgCl2) Sigma-Aldrich Cat#M8266
Zinc Chloride (ZnCl2) VMR Chemicals Cat#29156
Adenosine Triphosphate (ATP) Sigma-Aldrich Cat#A7699
HEPES Formedium Cat#HEPES10
Glycine VMR Chemicals Cat#10991U
Methanol Fisher Scientific Cat#67-56-1
Ammonium Persulfate BDH Cat#100323W
TEMED VWR chemicals Cat# 443083G
30% Bis Acrylamide Geneflow Cat# A2-0072
Fugene 6 Promega Cat# E2691
MG132 Merck Biosciences Cat# 474790
Bafilomycin A1 Enzo Life Sciences Cat#BML-CM110-0100
Opti-MEM Gibco Cat#31985
Experimental Models: Cell Lines
HEK293T ATCC RRID:CVCL_0063
Experimental Models: Organisms/Strain
pET15-Ubiquitin-6His-TAG6 MRC Reagents and Services
University of Dundee
DU29174
pET15-Ubiquitin-6His-TAG9 MRC Reagents and Services
University of Dundee
DU29175
pET15-Ubiquitin-6His-TAG11 MRC Reagents and Services
University of Dundee
DU29176
pET15-Ubiquitin-6His-TAG13 MRC Reagents and Services
University of Dundee
DU29177
pET15-Ubiquitin-6His-TAG14 MRC Reagents and Services
University of Dundee
DU29185
pET15-Ubiquitin-6His-TAG31 MRC Reagents and Services
University of Dundee
DU29178
pET15-Ubiquitin-6His-TAG32 MRC Reagents and Services
University of Dundee
DU29179
pET15-Ubiquitin-6His-TAG34 MRC Reagents and Services
University of Dundee
DU29180
pET15-Ubiquitin-6His-TAG40 MRC Reagents and Services
University of Dundee
DU29181
pET15-Ubiquitin-6His-TAG64 MRC Reagents and Services
University of Dundee
DU29182
pET15-Ubiquitin-6His-TAG72 MRC Reagents and Services
University of Dundee
DU29183
pET15b 6His UBCH5C S22R C85K MRC Reagents and Services
University of Dundee
DU29199
pET15b 6His UBCH5C S22R F62A C85K MRC Reagents and Services
University of Dundee
DU29756
pGEX6P-1-Cbl MRC Reagents and Services
University of Dundee *
DU12029
pGEX6P-1-Cbl Y371F MRC Reagents and Services
University of Dundee
DU65192
RNF4 (WT) Tatham et al., 2008 https://www.ncbi.nlm.nih.gov/pubmed/18408734
RNF4-RING Plechanovova´ et al., 2011 https://www.ncbi.nlm.nih.gov/pubmed/21857666
RNF4x-RING Plechanovova´ et al., 2011 https://www.ncbi.nlm.nih.gov/pubmed/21857666
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RNF4x-RINGx Plechanovova´ et al., 2011 https://www.ncbi.nlm.nih.gov/pubmed/21857666
SUMOx4 Tatham et al, 2008 https://www.ncbi.nlm.nih.gov/pubmed/18408734
Oligonucleotides
F Mut TAG6 (agaTATACATATGCAGATCTTCG
TGtAGACCCTGACTGGTAAGACCATCA C)
R mut TAG6GTGATGGTCTTACCAGTCAGGGT
CTaCACGAAGATCTGCATATGTATAtc t)
This Manuscript N/A
See Table S1 N/A
Software, Algorithms and Data Availability
MS Chemstation software Agilent Technologies N/A
Adobe Illustrator Adobe System, Inc. https://www.adobe.com/uk/products/illustrator.
html?sdid=88X75SKR&mv=search&ef_id=
EAIaIQobChMIxu_l2Zih5AIVibHtCh2ZqQcm
EAAYASAAEgKKUfD_BwE:G:s&s_kwcid=AL!3085!
3!340697722066!e!!g!!adobe%20illustrator&gclid=
EAIaIQobChMIxu_l2Zih5AIVibHtCh2ZqQcm
EAAYASAAEgKKUfD_BwE
ChemDraw PerkinElmer https://www.perkinelmer.com/category/chemdraw?
utm_source=Google&utm_medium=cpc&utm_
campaign=TEC-DG-GLO-INF-PPC-ZZ-GAW&sfdc_
id=7013A000001yj2V&LS=PPC&gclid=
EAIaIQobChMIweOr7pih5AIVF-DtCh0jAA_
WEAAYASAAEgJ6a_D_BwE
PyMOL PyMOL.org https://pymol.org/2/
Prism GraphPad N/A
Raw mass spectrometry data has been deposited https://data.mendeley.com http://dx.doi.org/10.17632/vv8spnwgyr.1
Other
4-12% NuPAGE Novex Bris- tris Mini-gels ThermoFisher Scientific NP0321BOX
Amicon Ultra-15 3 kDa MWCO centrifugal
filter device
Merck Cat#C7715
HiLoad Superdex-75 16/60 column GE Life Sciences Cat#28989333
PD-10 column GE Life Sciences Cat#17085101
UV lamp (BLE-8T365) Spectroline Cat# ENF280-C
Phos-TagTM MRC Reagents and Services
University of Dundee
https://mrcintranet.lifesci.dundee.ac.uk/mrc-reagents
L-glutamine Invitrogen Cat#25030024
Penicillin-streptomycin Invitrogen Cat#15140122
Dulbecco’s Modification of Eagle’s Medium
(DMEM)
Invitrogen Cat#11960-085
Fetal bovine serum (FBS) Sigma Aldrich Cat#F7524
SOC Media MRC Reagents and Services
University of Dundee
N/A
Luria-Bertani (LB) MRC Reagents and Services
University of Dundee
N/A
24-Well Plate Hampton Research Cat#HR3-158
Nitrocellulose membrane GE Life Sciences Cat#1060002
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H293T cells (donor sex: female) were obtained from ATCC. 293T is a human cell line, derived from the HEK293 cell line, that ex-
presses a mutant version of the SV40 large T antigen (RRID:CVCL_0063). Cells were cultured at 37C in a humidified incubator under
a 5 % CO2 atmosphere. Dulbecco’s modified Eagle medium was used and supplemented with fetal bovine serum and L-glutamine.
Escherichia coli BL21(DE3) or BL21 RosettaTM (DE3) cells used for protein expression in this study were grown in LB media sup-
plemented with 100 mg mL-1 of ampicillin and 34 mg mL-1 chloramphenicol (for details see STAR Methods - Expression of Recom-
binant Proteins).
METHODS DETAILS
Site-Specific Incorporation of pBpa Unnatural Amino Acid into Ubiquitin
pEvol-Bpa plasmid was derived from pEVOL-pBoF (kindly provided by P. Schultz, The Scripps Research Institute). Mutations for
incorporation of Bpa were introduced into both copies of MjYRS gene to make the plasmid pEVOL-Bpa (Young et al., 2010; Chin
et al., 2002). BL21 cells (50 mL) were co-transformed with the pET-Ubiquitin-6His-TAGx (where x is the Bpa incorporation site)
and pEvol-Bpa plasmids using heat shock and recovered in 200 mL SOC media at 37C for 1 hour and used to inoculate 50 mL
Luria-Bertani (LB) containing 100 mgmL-1 ampicillin and 34 mgmL-1 chloramphenicol. 10mL overnight culture was then used to inoc-
ulate 1 L LB broth containing the same concentrations of antibiotics. The cells were grown until OD600 reached 0.6 and the culture
was divided into two 500 mL portions. One portion was supplemented with 1 mM p-Benzoyl-L-phenylalanine (Bpa; Bachem) and the
other served as a control where Bpa was withheld. The cultures were incubated for 20 mins (37C, 200 rpm), or until the OD600
reached 0.6-0.7, and protein expression was induced by adding 0.02% arabinose and 1mM isopropyl b-D-1-thiogalactopyranoside
(IPTG). The cultures were incubated for 5 hours (37C, 200 rpm). The cells were harvested and suspended in 10 mL BugBuster
Protein Extraction (Merk Millipore) reagent before transferring to 50 mL falcon tube. The lysates were incubated for 20 minutes
and then clarified by centrifugation before transferring to 50 mL falcon tube containing 1 mL Ni-NTA agarose beads and incubated
for 1 hour with gentle shaking. The resin was centrifuged (4C, 1000 rpm) and washed with wash buffer (20 mM Na2HPO4, pH 7.5,
25 mM imidazole). Finally, the protein was eluted with 200 mL elution buffer (20 mM Na2HPO4, pH 7.5, 300 mM imidazole). A
20 mL aliquot from the elution fraction was mixed with equal amount of 4X SDS loading buffer and loaded onto 4-12% SDS-PAGE
gel. The proteins were separated at 200 V using MES buffer for 30 minutes and detected using Coomassie blue staining. A separate
20 mL protein was analyzed by LC-MS. LC-MS was carried out with an Agilent 1200 LC-MS system fitted with a Max-Light Cartridge
flow cell coupled to a 6130 Quadrupole spectrometer. An Agilent ZORBAX 300SB-C3 5 mm, 2.1 x 150 mm column was employed
unless otherwise stated. The solvent system consisted of 0.05% trifluoroacetic acid in H2O as buffer A, and 0.04%TFA acid in aceto-
nitrile as buffer B. Protein UV absorbance wasmonitored at 214 and 280 nm.MS acquisition was carried out in positive ion mode and
total protein masses were calculated by deconvolution within the MS Chemstation software (Agilent Technologies).
Fractions containing the pBpa incorporated-Ub were pooled concentrated with an Amicon Ultra-15 3 kDa MWCO centrifugal filter
device (Millipore). The sample was desalted into 10 mM Tris-HCl pH 7.5 using a PD-10 column (GE Life Sciences). DTT (1 mM) was
added to the sample, followed by hexahistidine tag cleavage with UCH-L3 (Virdee et al., 2010), at a final concentration of 15 mgmL-1.
The sample was incubated at 37C for 2 hours to remove the N-terminal His tag. Bpa incorporated-Ub was further purified by semi-
preparative HPLC and the fractions were lyophilized yielding approximately 4-6 mg of Ub-pBpa.
Expression of UBE2D3(S22R/C85K) Recombinant Protein
S22R and C85Kwere introduced into UBE2D3 by using site-directed mutagenesis. The cells were grown until OD600 reached 0.6-0.7
at 37C, 200 rpm. Once OD600 reached 0.60.7, protein expression was induced by adding IPTG (1 mM) and incubated at 37C for
3 h. The cells were harvested and resuspended in buffer (20 mM Na2HPO4, pH 7.5, 150 mM NaCl, 1 mM TCEP, complete protease
inhibitor cocktail (EDTA-free, Roche). Lysozyme was added (0.5 mg mL-1) and cells were incubated on ice for 30 min followed by
sonication. Clarified lysates containing His6-tagged UBE2D3(S22R/C85K) were loaded onto Ni-NTA resin and washed with buffer
(20 mM pH 7.5, Na2HPO4, pH 7.5, 25 mM imidazole, 150 mM NaCl, 1 mM TCEP), followed by elution with elution buffer (20 mM
pH 7.5, Na2HPO4, pH 7.5, 300 mM imidazole, 150 mM NaCl, 1 mM TCEP). Samples were further purified by size-exclusion chroma-
tography with a HiLoad Superdex-75 16/60 column (GE Healthcare) with running buffer (20 mM Na2HPO4, pH 7.5, 150 mM NaCl,
1 mM TCEP).
Preparation of Biotin-UbBpa31
Lyophilized UbBpa31 with an N-terminal MGCSSG cysteine-containing motif (10 mg) was reconstituted in 1 mL 10% DMSO/90%
0.5 mM TCEP (aq) and incubated at 23C for 45 mins with gentle mixing, followed by the addition of 5 molar equivalents of EZ-
link iodo-acetyl PEG2-Biotin (Thermofisher) in reaction buffer (50mMNa2HPO4, 150mMNaCl, 0.5mMTCEP). The reactionwas incu-
bated at 23Cwith gentle shaking for 1 h andmonitored to completion by LC-MS. Product was then purified by preparative HPLC at a
flow rate and lyophilized yielding biotin-UbBpa31 (6-8 mg).Cell Chemical Biology 27, 1–9.e1–e6, January 16, 2020 e4
Please cite this article in press as: Mathur et al., Photocrosslinking Activity-Based Probes for Ubiquitin RING E3 Ligases, Cell Chemical Biology (2019),
https://doi.org/10.1016/j.chembiol.2019.11.013Preparation of Isopeptide-linked photoABPs
To generate the photoABP-Bpa probes UBE2D3(S22R C85K) (200 mM) was incubated with UbBpa (200 mM) and His6–Uba1 (1 mM) at
35C for 26 h conjugation buffer (50 mM Tris, pH 10.0, 150 mM NaCl, 3 mM ATP, 5 mM MgCl2, 1 mM TCEP). The E2– UbBpa con-
jugate was applied onto a HiLoad 16/60 Superdex 75 gel filtration column (GE Healthcare) (20 mM HEPES, pH 7.5, 150 mM NaCl,
1 mM TCEP). The purified photoABP-Bpa probes were concentrated to 2 mg ml-1, and stored at -80C. Biotin-photoABP-Bpa31
probe was prepared using the same procedure.
Expression of Recombinant RNF4 Protein
Cloning, expression and purification of linear fusion of two RNF4 RING domains, and associated mutants, has been described pre-
viously (Plechanovova´ et al., 2011). The fusion of two RING domain of RNF4 were expressed in E. coli Rosetta (DE3) cells (Novagen).
The cells were grown until OD600 reached 0.60.7 at 37C, 200 rpm. Once the OD600 reached 0.6-0.7, the protein expression was
induced by adding IPTG (1 mM) and incubated overnight at 16C, 200 rpm.
The cells were harvested and resuspended in lysis buffer (50 mM Tris, pH 7.5, 0.5 M NaCl, 10 mM imidazole, 2 mM benzamidine,
complete protease inhibitor cocktail (EDTA-free, Roche)) and cells were lysed by sonication. His6-MBP-fusion proteins were purified
by Ni-NTA (Qiagen) chromatography, followed by cleavagewith TEV protease at 4C overnight. To remove any uncleaved fusion pro-
tein, His6-tagged MBP, as well as His6-tagged TEV protease, material was depleted against fresh Ni-NTA resin followed by size-
exclusion chromatographywith aHiLoadSuperdex 7516/60 column (GEHealthcare) (20mMTris, 150mMNaCl, 1mMTCEP, pH7.5).
Expression of c-Cbl and c-Cbl (Y371F) Recombinant Protein
BL21(DE3) cells (50 mL) were transformedwith the pGEX6P-1-Cbl plasmid and recovered in 200 mL SOCmedia at 37C for 1 hour and
used to inoculate 50 mL Luria-Bertani (LB) containing 100 mg mL-1 ampicillin. 10 mL overnight culture was then used to inoculate LB
broth containing the same concentration of antibiotic and 0.2 mM zinc chloride. The cells were grown until OD600 reached 0.6-0.7 at
37C, 200 rpm. Once the OD600 reached 0.60.7, protein expression was induced by adding 1 mM IPTG and left overnight at 16C,
200 rpm. The cells were harvested and resuspended in buffer (50 mM Hepes, pH 7.5, 0.5 M NaCl, 1 mM TCEP) and lysed by son-
ication. The lysates were incubated with glutathione sepharose beads for 1 hour with gentle shaking. The resin was centrifuged
(4C, 1000 rpm) and washed with buffer (50 mM HEPES, pH 7.5, 150 mM NaCl, 1 mM TCEP), followed by cleavage with Rhinovirus
3C protease at 4C overnight. Cleaved protein was further purified by size-exclusion chromatography with a HiLoad Superdex 200
16/600 column (GE Healthcare) (20 mM HEPES, 150 mM NaCl, 1 mM TCEP, pH 7.5).
c-Cbl Phosphorylation
Purified c-Cbl (3 mM)was phosphorylated by incubatingwith Src kinase (1.5 mM), 10mMMgCl2, 5mMATP at 37
C, 45mins. Samples
(15 ml) were collected and mixed well with 4X LDS loading buffer (ThermoFisher), followed by boiling before loading onto 7.5% acryl-
amide phos-tag gel. The proteins were separated at 160 V using MOPS buffer for 60 mins and analysed using Coomassie staining
and western blot.
Furthermore, ATP-dependent phosphorylation and photo-cross linking of c-Cbl with photoABP-Bpa31 (5 mM) was analysed using
Coomassie staining. Samples (15 ml) were collected andmixed well with 4X LDS loading buffer, followed by boiling them for 5 mins at
95C before loading onto 4-12% SDS-PAGE gel using MOPS running buffer and analysed using Coomassie staining. Moreover, gels
were blotted and analysed using western blot with anti-Cbl (1:5000 dilution) as primary and anti-mouse (1:10000 dilution) as second-
ary antibodies.
UV Irradiation Conditions for Photo-Cross-Linking
Photo-cross linking reactions (45 mL) were performed in a 24-well plate (Cryshem HR3-158, Hampton Research) in reaction buffer
(20 mM HEPES, pH 7.5, 150 mM NaCl, 1 mM TCEP). Samples were divided into two portions. One portion was irradiated at
365 nm on ice at a distance of 2 cm from a handled UV lamp (BLE-8T365, Spectroline), for 10-30 min and the other portion was pre-
served in the dark. For purified proteins such as RNF4-RING (5-10 mM), c-Cbl (3 mM) and c-Cbl Y371F (3 mM), photo-cross linking
reactions were performed with photoABP-Bpa31 probe (5-40 mM) and irradiated with UV. Samples were resolved by SDS-PAGE
and visualized by Coomassie staining or immunoblotting. Control experiments were performed under the same conditions.
Photo-Crosslinking in Cell Extracts
HEK293 cells were transfected with plasmids expressing GFP-Cbl, GST-Src andGFP-Cbl. The cells were lysed in lysis buffer (50mM
Na2HPO4, 10 mM Glycerophosphate, 50 mM Sodium Fluoride, 5 mM Sodium Pyrophosphate, 1 mM Sodium Vanadate, 0.25 M
Sucrose, 50 mMNaCl, 0.2 mM PMSF, 1 mM Benzamidine, 10 mM TCEP, 1% NP-40). Probe photoABP-Bpa31 (5-10 mM) was mixed
with cell lysate and UV irradiated (10 mins) using the photocrosslinking procedure described in the general method. Samples were
analysed by 4-12 % SDS-PAGE gel using MOPS running buffer (160 V, 60 mins) and visualized by immunoblotting with anti-Cbl
(1:5000 dilution) as primary and anti-mouse (1:10000 dilution) as secondary antibodies.
Phos-tag Gel Electrophoresis
To assess Src-mediated c-Cbl phosphorylation, we poured resolving gels (7.5 % acrylamide/bis-acrylamide, 375 mM Tris-HCl
pH 8.8, 0.1% sodium dodecyl sulfate (SDS), 100 mM MnCl2, 50 mM Phos-tag, 0.05 % (w/v) ammonium persulphate (APS),e5 Cell Chemical Biology 27, 1–9.e1–e6, January 16, 2020
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0.1%SDS, 0.05% (w/v) APS, 0.1% (v/v) TEMED), degassing with argon, then allowing polymerization at room temperature for three
hours. Cell extracts (50 mg) were boiled in LDS-sample buffer and supplemented with 10 mMMnCl2 before loading. Electrophoresis
was performed at 70 V through the stacking gel and 130 V through the resolving gel using running buffer (25 mM Tris-HCl, 192 mM
Glycine, 0.1% SDS), before staining with Coomassie dye, or washing 3 x 20 min in transfer buffer (48 mM Tris-HCl, 39 mM glycine,
20% methanol) supplemented with 10 mM EDTA and 0.05 % SDS to chelate manganese, followed by 1 x 20 min in transfer buffer
supplemented with 0.05 % SDS. Protein was then transferred to 0.45 mm nitrocellulose membrane in transfer buffer at 100 V,
3 hr, 4C.
Cell Culture, Transfection and Lysis
293T cells were cultured (37C, 5%CO2) in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% (v/v) fetal bovine
serum (FBS), 2.0 mM ʟ-glutamine and antibiotics (100 units mL-1 penicillin, 0.1mgmL-1 streptomycin). Cells were seeded at a density
of 4 x 106 in 100 mm dishes. 18 hr post seeding, cell transfections (2 mg DNA, empty vector (pcDNA (Thermo Fisher)), pcDNA and
GST-Src, pcDNA and GFP-c-Cbl, or GST-Src and GFP-c-Cbl) were performed using 5 mL Fugene-6 (Promega) in 200 mL Eagle’s
Minimum Essential Medium (Opti-MEM). MG132 (25 mM) was added to cells 90 min before harvesting. Cells were rinsed and
collected with ice-cold PBS, and extracted with ice-cold lysis buffer (50 mM Tris-HCl pH 7.5, 10 mM sodium 2-glycerophosphate,
50 mM sodium fluoride, 5.0 mM sodium pyrophosphate, 1.0 mM sodium orthovanadate, 0.27 M sucrose, 50 mMNaCl, 0.2 mM phe-
nylmethanesulfonyl fluoride (PMSF), 1.0 mM benzamidine, 10 mM TCEP, 1% NP-40) on ice for 30 min. Lysates were clarified by
centrifugation at 4C for 20 min at 21,100g. Supernatants were collected and protein concentration was determined by Brad-
ford assay.
Activity-Based Proteomic Profiling of EGF-Stimulated HEK293 Cells
293T cells were seeded in 150mmdishes at a density of 5 x 106 and cultured (37C, 5%CO2) in Dulbecco’smodified Eagle’smedium
(DMEM) supplemented with 10 % (v/v) fetal bovine serum (FBS), 2.0 mM ʟ-glutamine and antibiotics (100 units mL-1 penicillin,
0.1 mgmL-1 streptomycin). The next day, media was replaced for DMEM lacking FBS. The following day, cells were treated with
20 mM MG132 and 200 nM Bafilomycin for 6 hours at 37C, then with or without recombinant EGF 100 ngmL-1 (Thermo Fisher Sci-
entific, PHG0311) for 15minutes at 37C. Disheswere transferred on to ice, washed, resuspended in ice-cold PBS, andwashed twice
at 4C, and lysates extracted in ice-cold lysis buffer. 293T cells were treated with biotinylated probe (biotin-photoABP-Bpa31)
(10 mM). Samples were divided and irradiated with UV for 1 hour or UV was withheld. Biotin enrichment was then carried out against
streptavidin resin followed by on-resin tryptic digestion and LC-MS/MS analysis and data processing, as previously described, with
an exception being hardware parametrization with an inclusion list of theoretical Cbl tryptic peptides (Pao et al., 2018).
QUANTIFICATION AND STATISTICAL ANALYSIS
Data were presented as mean ± standard error determined from technical replicate. Statistical analysis was performed with
GraphPad Prism (version 6.0). Figures 4E, S4H, and S4I were filtered against the PFAM domain terms ‘‘RING, HECT, IBR, zf-UBR
and DUBs’’. All biological experiments were performed at least twice.
DATA AND CODE AVAILBILITY
The mass spectrometry raw data files have been deposited in the Mendeley database (https://dx.doi.org/10.17632/vv8spnwgyr.1).Cell Chemical Biology 27, 1–9.e1–e6, January 16, 2020 e6
